| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,785 | 16,546 | 17,370 | 29,435 | | Cost of Revenue | 19,779 | 10,271 | 11,343 | 20,194 | | | Gross Profit | 10,006 | 6,275 | 6,027 | 9,240 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,573 | 1,455 | 1,643 | 1,051 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,433 | 4,820 | 4,384 | 8,189 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (829) | (5,819) | 143 | 16 | | Earnings Before Interest And Taxes | 6,604 | (1,000) | 4,527 | 8,205 | | Interest Expense |
-
|
-
|
-
| 28 | | Income Before Tax | 6,604 | (1,000) | 4,527 | 8,177 | | Income Tax Expense | 1,891 | 993 | 1,145 | 1,851 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,713 | (1,992) | 3,382 | 6,326 | | | Non-recurring Events | | Discontinued Operations | (771) | (593) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,713 | (2,585) | 3,382 | 6,326 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,713 | ($2,585) | $3,382 | $6,326 |
|
0.68% Nasdaq 
Income Statement
